Highly Porous Type II Collagen-Containing Scaffolds for Enhanced Cartilage Repair with Reduced Hypertrophic Cartilage Formation
Open Access
- 26 May 2022
- journal article
- research article
- Published by MDPI AG in Bioengineering
- Vol. 9 (6) , 232
Abstract
The ability to regenerate damaged cartilage capable of long-term performance in an active joint remains an unmet clinical challenge in regenerative medicine. Biomimetic scaffold biomaterials have shown some potential to direct effective cartilage-like formation and repair, albeit with limited clinical translation. In this context, type II collagen (CII)-containing scaffolds have been recently developed by our research group and have demonstrated significant chondrogenic capacity using murine cells. However, the ability of these CII-containing scaffolds to support improved longer-lasting cartilage repair with reduced calcified cartilage formation still needs to be assessed in order to elucidate their potential therapeutic benefit to patients. To this end, CII-containing scaffolds in presence or absence of hyaluronic acid (HyA) within a type I collagen (CI) network were manufactured and cultured with human mesenchymal stem cells (MSCs) in vitro under chondrogenic conditions for 28 days. Consistent with our previous study in rat cells, the results revealed enhanced cartilage-like formation in the biomimetic scaffolds. In addition, while the variable chondrogenic abilities of human MSCs isolated from different donors were highlighted, protein expression analysis illustrated consistent responses in terms of the deposition of key cartilage extracellular matrix (ECM) components. Specifically, CI/II-HyA scaffolds directed the greatest cell-mediated synthesis and accumulation in the matrices of type II collagen (a principal cartilage ECM component), and reduced deposition of type X collagen (a key protein associated with hypertrophic cartilage formation). Taken together, these results provide further evidence of the capability of these CI/II-HyA scaffolds to direct enhanced and longer-lasting cartilage repair in patients with reduced hypertrophic cartilage formation.Keywords
Funding Information
- European Union’s Horizon 2020 (721432, 788753)
- European Research Council (ERC) (721432, 788753)
This publication has 48 references indexed in Scilit:
- Cartilaginous Extracellular Matrix-Modified Chitosan Hydrogels for Cartilage Tissue EngineeringACS Applied Materials & Interfaces, 2014
- Addition of hyaluronic acid improves cellular infiltration and promotes early-stage chondrogenesis in a collagen-based scaffold for cartilage tissue engineeringJournal of the Mechanical Behavior of Biomedical Materials, 2012
- Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritisTherapeutic Advances in Musculoskeletal Disease, 2012
- Biomaterials & scaffolds for tissue engineeringMaterials Today, 2011
- The metabolism of human mesenchymal stem cells during proliferation and differentiationJournal of Cellular Physiology, 2010
- Extracellular matrix-induced transforming growth factor-β receptor signaling dynamicsOncogene, 2010
- Novel Freeze-Drying Methods to Produce a Range of Collagen–Glycosaminoglycan Scaffolds with Tailored Mean Pore SizesTissue Engineering Part C: Methods, 2009
- Collagen Type II Enhances Chondrogenesis in Adipose Tissue–Derived Stem Cells by Affecting Cell ShapeTissue Engineering Part A, 2009
- Chondrogenic Potential of Human Adult Mesenchymal Stem Cells Is Independent of Age or Osteoarthritis EtiologyStem Cells, 2007
- Thionin Staining of Paraffin and Plastic Embedded Sections of CartilageBiotechnic & Histochemistry, 1993